Top Abstract Prizes

Arianna Andreozzi: UNDERWATER VERSUS CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLORECTAL NEOPLASIA: A MULTICENTER, RANDOMISED CONTROLLED TRIAL

Emma Culver: OBEXELIMAB, A B CELL INHIBITOR, IN IGG4-RELATED DISEASE, INCLUDING PATIENTS WITH PANCREATOBILIARY INVOLVEMENT: RESULTS FROM THE PHASE 3 INDIGO TRIAL 

Dania El Abyad: EPITHELIAL PLASTICITY REGULATES IMMUNE CHECKPOINT BARRIERS IN CHRONIC LIVER DISEASE

Nurulamin Noor: PROFILE TRIAL 5-YEAR FOLLOW-UP SHOWS EARLY “TOP-DOWN” ANTI-TNF THERAPY RESULTS IN HIGH TREATMENT DURABILITY AND MODIFIES THE COURSE OF CROHN’S DISEASE

Anouk Overdevest: ONE DAY OF ANTIBIOTIC TREATMENT IS NON-INFERIOR TO 4-7 DAYS IN PATIENTS WITH ACUTE CHOLANGITIS AFTER ADEQUATE BILIARY DRAINAGE: A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL (COBRA)

Janne Scheepers: DEFINING THE OPTIMAL STRATEGY FOR PROTON PUMP INHIBITOR DEPRESCRIBING: RESULTS FROM THE PEPPER TRIAL

A huge congratulations to our distinguished UEG Week Top Abstract Prize Awardees 2026! Be sure to join the award ceremony live during our Opening Plenary on Sunday, October 18! 

Access programme

All abstracts submitted for UEG Week 2026 will be considered for these prizes. Nominees have to provide details of how the prize money will be spent on future research. In the situation of industry involvement, the prize money must be waived.

Prizes are awarded to the presenter, who will be featured in UEG publications. Recipients are expected to submit an article to UEG Journal.

Target group

• All submitters of abstracts will be considered.
• No age limit.
• This opportunity is only available for UEG Associates.